[1]
R. Bolaños-Díaz, R. A. Tejada, C. Sanabria, and S. Escobedo-Palza, “Cost-effectiveness of two antiviral therapies for chronic hepatitis B in Peru: entecavir and tenofovir”, Rev Peru Med Exp Salud Publica, vol. 34, no. 3, pp. 377–85, Sep. 2017, doi: 10.17843/rpmesp.2017.343.2496.